# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-25-008281
Filing Date
2025-02-26
Accepted
2025-02-26 08:30:53
Documents
29
Period of Report
2025-02-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 38083
2 |  | ex99-1.htm | EX-99.1 | 15129
3 |  | ex99-1_001.jpg | GRAPHIC | 1766445
4 |  | ex99-1_002.jpg | GRAPHIC | 2813837
5 |  | ex99-1_003.jpg | GRAPHIC | 2121161
6 |  | ex99-1_004.jpg | GRAPHIC | 1811817
7 |  | ex99-1_005.jpg | GRAPHIC | 2075057
8 |  | ex99-1_006.jpg | GRAPHIC | 2117503
9 |  | ex99-1_007.jpg | GRAPHIC | 1665753
10 |  | ex99-1_008.jpg | GRAPHIC | 1320933
11 |  | ex99-1_009.jpg | GRAPHIC | 1543928
12 |  | ex99-1_010.jpg | GRAPHIC | 1539940
13 |  | ex99-1_011.jpg | GRAPHIC | 2325591
14 |  | ex99-1_012.jpg | GRAPHIC | 1849481
15 |  | ex99-1_013.jpg | GRAPHIC | 1758700
16 |  | ex99-1_014.jpg | GRAPHIC | 2121531
17 |  | ex99-1_015.jpg | GRAPHIC | 1065998
| Complete submission text file | 0001493152-25-008281.txt |  | 38594238

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
18 | XBRL SCHEMA FILE | envb-20250226.xsd | EX-101.SCH | 3012
19 | XBRL LABEL FILE | envb-20250226_lab.xml | EX-101.LAB | 34240
20 | XBRL PRESENTATION FILE | envb-20250226_pre.xml | EX-101.PRE | 22357
31 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3827

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 25666283
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)